Heier Jeffrey S. 4
4 · OCULAR THERAPEUTIX, INC · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Heier Jeffrey S.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-02+17,350→ 17,350 totalExercise: $4.30Exp: 2033-08-01→ Common Stock (17,350 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continued service as a consultant to the Company, the option will vest over one year, with 1/12 of the shares underlying the option vesting monthly beginning on the one-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date for this award is July 1, 2023.